Cell Counting Kit-8 (CCK-8) analysis showed that EIF4A3-KD inhibited the proliferative capacity of GBM cells compared to the negative control (NC) (Fig. 2b), whereas EIF4A3-OE enhanced the proliferation of GBM cells (Figure S1b). The gene discussed is EIF4A3; the disease is glioblastoma.